 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in 2016 and is headquartered in Philadelphia, PA.

Current Price	$6.10
Prev Close	$6.08
Open	$6.11
Dividend Yield	0.00%
50-Day Moving Average	$4.64
Beta	1.12
Avg. Volume	184,444.73
PE Ratio	-1.59

52-Week High	$7.40
52-Week Low	$0.6436
Market Capitalization	$245.55M
EPS	-$3.84
Price to Book	2.85
Revenue Per Employee	$2.54M
Enterprise Value/EBITDA	2.06

CARM Carisma Therapeutics Inc

About

Feed

Fundamentals

News